Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Essmann

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Nucleic Acids Research|September 2, 2009
Adaptation of topoisomerase I paralogs to nuclear and mitochondrial DNAIlaria Dalla Rosa, Steffi Goffart, Melanie Wurm, et al.
Cell Death & Disease|April 24, 2024
ATF3 characterizes aggressive drug-tolerant persister cells in HGSOCKathrin Böpple, Yaara Oren, Whitney S Henry, et al.
Cell Cycle (Georgetown, Tex.)|November 20, 2010
The centrosome and mitotic spindle apparatus in cancer and senescenceStephen Schmidt, Frank Essmann, Ion C Cirstea, et al.
EMBO Reports|July 24, 2024
BCL-2 and BOK regulate apoptosis by interaction of their C-terminal transmembrane domainsTobias B Beigl, Alexander Paul, Thomas P Fellmeth, et al.
Cell Death & Disease|May 27, 2026
Inhibition of RNA polymerase II-activating CDK9 and CDK12/13, but not of cell cycle relevant CDKs, induces apoptosis by downregulating the short-lived Bcl-2 proteins Mcl1 and Bfl1/A1Karina S Krings, Judith Hatzfeld, Sandra Weller, et al.
Cell Cycle (Georgetown, Tex.)|September 20, 2013
Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR)Christoph Garbers, Fabian Kuck, Samadhi Aparicio-Siegmund, et al.
Cell Death & Disease|January 31, 2026
BCL-xL as a therapeutic target in cetuximab-refractory colorectal cancerStella Asmanidou, Julia Thiel, Thomas L Ekstrom, et al.
Cell & Bioscience|April 28, 2022
PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapyThomas Fischer, Oliver Hartmann, Michaela Reissland, et al.
Science Advances|March 18, 2026
KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survivalThomas L Ekstrom, Zhangshuai Dai, Julia Thiel, et al.
Cancer Research|July 23, 2013
SOX2 expression associates with stem cell state in human ovarian carcinomaPetra M Bareiss, Anna Paczulla, Hui Wang, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Nucleic Acids Research|September 2, 2009
Adaptation of topoisomerase I paralogs to nuclear and mitochondrial DNAIlaria Dalla Rosa, Steffi Goffart, Melanie Wurm, et al.
Cell Death & Disease|April 24, 2024
ATF3 characterizes aggressive drug-tolerant persister cells in HGSOCKathrin Böpple, Yaara Oren, Whitney S Henry, et al.
Cell Cycle (Georgetown, Tex.)|November 20, 2010
The centrosome and mitotic spindle apparatus in cancer and senescenceStephen Schmidt, Frank Essmann, Ion C Cirstea, et al.
EMBO Reports|July 24, 2024
BCL-2 and BOK regulate apoptosis by interaction of their C-terminal transmembrane domainsTobias B Beigl, Alexander Paul, Thomas P Fellmeth, et al.
Cell Death & Disease|May 27, 2026
Inhibition of RNA polymerase II-activating CDK9 and CDK12/13, but not of cell cycle relevant CDKs, induces apoptosis by downregulating the short-lived Bcl-2 proteins Mcl1 and Bfl1/A1Karina S Krings, Judith Hatzfeld, Sandra Weller, et al.
Cell Cycle (Georgetown, Tex.)|September 20, 2013
Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR)Christoph Garbers, Fabian Kuck, Samadhi Aparicio-Siegmund, et al.
Cell Death & Disease|January 31, 2026
BCL-xL as a therapeutic target in cetuximab-refractory colorectal cancerStella Asmanidou, Julia Thiel, Thomas L Ekstrom, et al.
Cell & Bioscience|April 28, 2022
PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapyThomas Fischer, Oliver Hartmann, Michaela Reissland, et al.
Science Advances|March 18, 2026
KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survivalThomas L Ekstrom, Zhangshuai Dai, Julia Thiel, et al.
Cancer Research|July 23, 2013
SOX2 expression associates with stem cell state in human ovarian carcinomaPetra M Bareiss, Anna Paczulla, Hui Wang, et al.
Pageof 7